Catalyst Pharmaceuticals
CPRX
#3844
Rank
โ‚ฌ2.42 B
Marketcap
20,37ย โ‚ฌ
Share price
-0.89%
Change (1 day)
35.44%
Change (1 year)

EPS for Catalyst Pharmaceuticals (CPRX)

EPS in 2023 (TTM): 1,04ย โ‚ฌ

According to Catalyst Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 1,05ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 0,77ย โ‚ฌ an increase over its 2021 EPS that were of 0,36ย โ‚ฌ.

EPS history for Catalyst Pharmaceuticals from 2004 to 2023

Annual EPS

Year EPS Change
2023 (TTM)1,04ย โ‚ฌ35.18%
20220,77ย โ‚ฌ110.53%
20210,36ย โ‚ฌ-47.22%
20200,69ย โ‚ฌ132.26%
20190,30ย โ‚ฌ-191.18%
2018-0,33ย โ‚ฌ54.55%
2017-0,21ย โ‚ฌ-4.35%
2016-0,22ย โ‚ฌ-8%
2015-0,24ย โ‚ฌ4.17%
2014-0,23ย โ‚ฌ-11.11%
2013-0,26ย โ‚ฌ107.69%
2012-0,12ย โ‚ฌ-55.17%
2011-0,28ย โ‚ฌ31.82%
2010-0,21ย โ‚ฌ-55.1%
2009-0,47ย โ‚ฌ-39.51%
2008-0,78ย โ‚ฌ145.45%
2007-0,32ย โ‚ฌ-8.33%
2006-0,34ย โ‚ฌ-28.71%
2005-0,48ย โ‚ฌ180.56%
2004-0,17ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
0,75ย โ‚ฌ-29.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-7,50ย โ‚ฌ-811.82%๐Ÿ‡บ๐Ÿ‡ธ USA
13,49ย โ‚ฌ 1,180.48%๐Ÿ‡บ๐Ÿ‡ธ USA
-9,36ย โ‚ฌ-988.86%๐Ÿ‡บ๐Ÿ‡ธ USA
1,78ย โ‚ฌ 69.09%๐Ÿ‡บ๐Ÿ‡ธ USA
2,85ย โ‚ฌ 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA